Biotech Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement October 29, 2024
Biotech WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development October 28, 2024
Biotech BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting October 28, 2024
Biotech IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors October 28, 2024
Biotech ADVANCED NANOTHERAPIES ANNOUNCES POSITIVE RESULTS IN ITS FIRST-IN-HUMAN TRIAL AND PLANS FOR U.S. EARLY FEASIBILITY STUDY FOR SIRPLUX™ DUO DRUG-COATED BALLOON October 27, 2024
Biotech RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation October 26, 2024
Biotech Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast October 26, 2024
Biotech Meret Gaugler, PhD, joins Page Therapeutics as independent member of the Board of Directors October 25, 2024
Biotech IDEAYA Announces Positive Interim Phase 1 Expansion Data of IDE397 in MTAP-Deletion Urothelial and Lung Cancer as Late-Breaker Oral Presentation at EORTC-NCI-AACR 2024 October 25, 2024